SCOTUS rules in Life Tech v Promega: One is not enough

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

SCOTUS rules in Life Tech v Promega: One is not enough

February 23, 2017
Life technologies 165

The Supreme Court has reversed the Federal Circuit in Life Tech v Promega, ruling that manufacture and exportation of a single component of a patented invention assembled in another country is not enough for infringement in the US. However, as a concurring opinion and observers note, the court did not indicate how much more than one is enough

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

United StatesNewsPatentsNorth AmericaJurisdictions
more from across site and ros bottom lb

More from across our site

Awards
Copy of EMEA awards 2024-Shortlist Announced-1200x627.png
LMG Life Sciences Awards EMEA 2025: open for entries
It is time to make your nominations to the sixth annual Life Sciences Awards EMEA
John Harrison, December 19, 2024
Trade Secrets
Photo_Keejeong KIM - #3680325v1_AD_.jpg
Bigger and better: why former Yulchon partner returned home
Keejeong Kim, who returned to Yulchon after a four-year gap, said he was intrigued by the opportunity to work on neighbouring areas of law to IP
Sukanya Sarkar, December 19, 2024
Patents
investment.jpg
Lumenci eyes accelerated growth with private equity investment
The IP consulting firm hopes to expand its services and outreach with the support of investors VSS Capital Partners and Century Equity Partners
Sukanya Sarkar, December 19, 2024
Patents
Dexcom headquarters building exterior. DexCom, Inc. develops, manufactures, and distributes glucose monitoring systems for diabetes management. - San Diego, California, USA - 2020
UPC latest: CoA decision has retroactive effect | Dexcom defeat | 2025 predictions
This update includes a ruling from the Court of Appeal, a judgment of the Paris Local Division, news of upcoming hearings, and predictions for 2025
James Nurton, December 19, 2024
Copyright
Generative AI.jpeg
2024 review: counsel plagued by AI uncertainty and copyright questions
US counsel review the key copyright and trademark trends of 2024, including generative AI disputes and SCOTUS cases
Rani Mehta, December 18, 2024
Patents
Silhouette of business man following his ambitions, Generative Ai illustration
Weekly take: Consolidation and IP transactions in firms’ 2025 sights
If 2024 is anything to go by, the next 12 months could see more IP firms seek investment opportunities while IP lawyers are increasingly likely to work alongside other functions
Max Walters, December 18, 2024
Patents
2024-comp.jpg
2024 review: US counsel reflect on top patent trends
Practitioners reflect on the impact of USPTO guidance, as well as PTAB and litigation trends
Rani Mehta, December 18, 2024
Patents
MIP Podcast newsletter header banner sample-2000.jpg
The IP Lounge: Top 50 people in IP | social media habits
We discuss Managing IP’s 50 most influential people in IP list and look back on the biggest talking points in the last month
Max Walters, December 16, 2024
Patents
QnA or questions and answers concept. Blue magnifying glass with question symbol on wooden cube over a blue background.
How lawyers quiz jurors in trade secrets disputes
Firms explain how they question jurors and account for potential bias in trade secrets cases
Rani Mehta, December 13, 2024
Patents
Vintage Beatles Monthly Book
This week on MIP: EPO meets Ericsson | Ex-Beatle backs AI regs
A meeting between the EPO and Ericsson, Paul McCartney weighing in on AI and copyright, and a law firm’s STEM pledge were among the top talking points
Max Walters, December 13, 2024
Gift this article